Patients Overpay For Prescriptions 23% Of The Time, Analysis Shows
(By Sydney Lupkin for Kaiser Health News) As a health economist, Karen Van Nuys had heard that it’s sometimes cheaper
Read More
Month: March 2018
Most cyberattacks cause 4 hours of downtime: 7 things to know
(By Julie Spitzer for Becker’s Hospital Review) Physicians may need more cybersecurity training and education, according to a recent American
Read More340B hospitals provided $26M+ in uncompensated, unreimbursed care: 3 study findings
(By Kelly Gooch for Becker’s Hospital Review) Hospitals and health systems that participate in the 340B Drug Pricing Program play
Read MoreLifting Therapy Caps Proves A Load Off Medicare Patients’ Shoulders
(By Susan Jaffe for Kaiser Health News) Physical therapy helps Leon Beers, 73, get out of bed in the morning
Read MoreOpioid Maker Funds Efforts To Fight Addiction: Is It ‘Blood Money’ Or Charity?
(By Jenny Gold for Kaiser Health News) A program to give naloxone overdose-antidote kits and training to front-line officers. Funding
Read MoreSome healthcare employees willing to sell patient data
According to a new survey from Accenture claims, nearly one in five employees in the healthcare field said they are
Read MoreWhat is Artificial Intelligence role in healthcare?
Confusion surrounding Artificial Intelligence and its applications in healthcare remains widespread. AI is shorthand for any task a computer can
Read MoreSome Anthem patients afraid to use ED under new policy: 6 things to know
(By Morgan Haefner for Becker’s Hospital Review) Ohio residents with Anthem insurance told The Plain Dealer they fear Anthem’s discretionary
Read MoreHSA use among employees seems to have slowed
The Employee Benefit Research Institute reports that while estimates from five different surveys on the adoption of HSA-eligible health plans and HSAs themselves
Read MoreAmid efforts to expand naloxone access, a controversial new study questions its value
(By Lev Facher for STAT) WASHINGTON — Amid a worsening opioid epidemic, the overdose-reversal drug naloxone has taken center stage.
Read More